Observational studyAlimentary pharmacology & therapeutics2018

Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes.

S Van Hees et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.